カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の子宮筋腫塞栓装置市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Uterine Fibroid Embolization Device Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO18708）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO18708
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：115
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の子宮筋腫塞栓装置市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

子宮筋腫塞栓装置市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の子宮筋腫塞栓装置の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

子宮筋腫塞栓装置市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・ゼラチンスポンジ、ポリビニルアルコール ( PVA ) 微粒子、トリスアクリルゼラチン微粒子 ( TAGM )、ポリメチルメタクリレート ( PMMA ) 微粒子

用途別セグメントは次のように区分されます。
・病院、診療所

世界の子宮筋腫塞栓装置市場の主要な市場プレーヤーは以下のとおりです。
・Boston Scientific Corporation、Merit Medical Systems、BioSpace、Hologic, Inc.、Cook Medical、Ferring B.V.、Smith+Nephew、CooperSurgical, Inc.、Aetna Better Health of Pennsylvania、Ethicon US, LLC、Olympus America、Stryker、Astellas Pharma、Nippon Kayaku、Pfizer

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、子宮筋腫塞栓装置製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な子宮筋腫塞栓装置メーカーの企業概要、2019年～2022年までの子宮筋腫塞栓装置の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な子宮筋腫塞栓装置メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別子宮筋腫塞栓装置の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの子宮筋腫塞栓装置の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での子宮筋腫塞栓装置市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および子宮筋腫塞栓装置の産業チェーンを掲載しています。
・第13、14、15章では、子宮筋腫塞栓装置の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 子宮筋腫塞栓装置の概要
- 種類別分析（2017年vs2021年vs2028年）：ゼラチンスポンジ、ポリビニルアルコール ( PVA ) 微粒子、トリスアクリルゼラチン微粒子 ( TAGM )、ポリメチルメタクリレート ( PMMA ) 微粒子
- 用途別分析（2017年vs2021年vs2028年）：病院、診療所
- 世界の子宮筋腫塞栓装置市場規模・予測
- 世界の子宮筋腫塞栓装置生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Boston Scientific Corporation、Merit Medical Systems、BioSpace、Hologic, Inc.、Cook Medical、Ferring B.V.、Smith+Nephew、CooperSurgical, Inc.、Aetna Better Health of Pennsylvania、Ethicon US, LLC、Olympus America、Stryker、Astellas Pharma、Nippon Kayaku、Pfizer
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：ゼラチンスポンジ、ポリビニルアルコール ( PVA ) 微粒子、トリスアクリルゼラチン微粒子 ( TAGM )、ポリメチルメタクリレート ( PMMA ) 微粒子
・用途別分析2017年-2028年：病院、診療所
・子宮筋腫塞栓装置の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・子宮筋腫塞栓装置のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・子宮筋腫塞栓装置のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・子宮筋腫塞栓装置の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・子宮筋腫塞栓装置の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Uterine Fibroid Embolization Device market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Uterine Fibroid Embolization Device market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Hospitals accounting for % of the Uterine Fibroid Embolization Device global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Gelatin Sponge segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Uterine Fibroid Embolization Device include Boston Scientific Corporation, Merit Medical Systems, BioSpace, Hologic, Inc., and Cook Medical, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Uterine Fibroid Embolization Device market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Gelatin Sponge
Polyvinyl Alcohol ( PVA ) Particles
Trisacryl Gelatin Microspheres ( TAGM )
Polymethyl Methacrylate ( PMMA ) Microspheres
Market segment by Application can be divided into
Hospitals
Clinics
The key market players for global Uterine Fibroid Embolization Device market are listed below:
Boston Scientific Corporation
Merit Medical Systems
BioSpace
Hologic, Inc.
Cook Medical
Ferring B.V.
Smith+Nephew
CooperSurgical, Inc.
Aetna Better Health of Pennsylvania
Ethicon US, LLC
Olympus America
Stryker
Astellas Pharma
Nippon Kayaku
Pfizer
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Uterine Fibroid Embolization Device product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Uterine Fibroid Embolization Device, with price, sales, revenue and global market share of Uterine Fibroid Embolization Device from 2019 to 2022.
Chapter 3, the Uterine Fibroid Embolization Device competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Uterine Fibroid Embolization Device breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Uterine Fibroid Embolization Device market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Uterine Fibroid Embolization Device.
Chapter 13, 14, and 15, to describe Uterine Fibroid Embolization Device sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Uterine Fibroid Embolization Device Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Uterine Fibroid Embolization Device Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Gelatin Sponge
1.2.3 Polyvinyl Alcohol ( PVA ) Particles
1.2.4 Trisacryl Gelatin Microspheres ( TAGM )
1.2.5 Polymethyl Methacrylate ( PMMA ) Microspheres
1.3 Market Analysis by Application
1.3.1 Overview: Global Uterine Fibroid Embolization Device Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Uterine Fibroid Embolization Device Market Size & Forecast
1.4.1 Global Uterine Fibroid Embolization Device Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Uterine Fibroid Embolization Device Sales in Volume (2017-2028)
1.4.3 Global Uterine Fibroid Embolization Device Price (2017-2028)
1.5 Global Uterine Fibroid Embolization Device Production Capacity Analysis
1.5.1 Global Uterine Fibroid Embolization Device Total Production Capacity (2017-2028)
1.5.2 Global Uterine Fibroid Embolization Device Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Uterine Fibroid Embolization Device Market Drivers
1.6.2 Uterine Fibroid Embolization Device Market Restraints
1.6.3 Uterine Fibroid Embolization Device Trends Analysis
2 Manufacturers Profiles
2.1 Boston Scientific Corporation
2.1.1 Boston Scientific Corporation Details
2.1.2 Boston Scientific Corporation Major Business
2.1.3 Boston Scientific Corporation Uterine Fibroid Embolization Device Product and Services
2.1.4 Boston Scientific Corporation Uterine Fibroid Embolization Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Merit Medical Systems
2.2.1 Merit Medical Systems Details
2.2.2 Merit Medical Systems Major Business
2.2.3 Merit Medical Systems Uterine Fibroid Embolization Device Product and Services
2.2.4 Merit Medical Systems Uterine Fibroid Embolization Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 BioSpace
2.3.1 BioSpace Details
2.3.2 BioSpace Major Business
2.3.3 BioSpace Uterine Fibroid Embolization Device Product and Services
2.3.4 BioSpace Uterine Fibroid Embolization Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Hologic, Inc.
2.4.1 Hologic, Inc. Details
2.4.2 Hologic, Inc. Major Business
2.4.3 Hologic, Inc. Uterine Fibroid Embolization Device Product and Services
2.4.4 Hologic, Inc. Uterine Fibroid Embolization Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Cook Medical
2.5.1 Cook Medical Details
2.5.2 Cook Medical Major Business
2.5.3 Cook Medical Uterine Fibroid Embolization Device Product and Services
2.5.4 Cook Medical Uterine Fibroid Embolization Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Ferring B.V.
2.6.1 Ferring B.V. Details
2.6.2 Ferring B.V. Major Business
2.6.3 Ferring B.V. Uterine Fibroid Embolization Device Product and Services
2.6.4 Ferring B.V. Uterine Fibroid Embolization Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Smith+Nephew
2.7.1 Smith+Nephew Details
2.7.2 Smith+Nephew Major Business
2.7.3 Smith+Nephew Uterine Fibroid Embolization Device Product and Services
2.7.4 Smith+Nephew Uterine Fibroid Embolization Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 CooperSurgical, Inc.
2.8.1 CooperSurgical, Inc. Details
2.8.2 CooperSurgical, Inc. Major Business
2.8.3 CooperSurgical, Inc. Uterine Fibroid Embolization Device Product and Services
2.8.4 CooperSurgical, Inc. Uterine Fibroid Embolization Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Aetna Better Health of Pennsylvania
2.9.1 Aetna Better Health of Pennsylvania Details
2.9.2 Aetna Better Health of Pennsylvania Major Business
2.9.3 Aetna Better Health of Pennsylvania Uterine Fibroid Embolization Device Product and Services
2.9.4 Aetna Better Health of Pennsylvania Uterine Fibroid Embolization Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Ethicon US, LLC
2.10.1 Ethicon US, LLC Details
2.10.2 Ethicon US, LLC Major Business
2.10.3 Ethicon US, LLC Uterine Fibroid Embolization Device Product and Services
2.10.4 Ethicon US, LLC Uterine Fibroid Embolization Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Olympus America
2.11.1 Olympus America Details
2.11.2 Olympus America Major Business
2.11.3 Olympus America Uterine Fibroid Embolization Device Product and Services
2.11.4 Olympus America Uterine Fibroid Embolization Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Stryker
2.12.1 Stryker Details
2.12.2 Stryker Major Business
2.12.3 Stryker Uterine Fibroid Embolization Device Product and Services
2.12.4 Stryker Uterine Fibroid Embolization Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Astellas Pharma
2.13.1 Astellas Pharma Details
2.13.2 Astellas Pharma Major Business
2.13.3 Astellas Pharma Uterine Fibroid Embolization Device Product and Services
2.13.4 Astellas Pharma Uterine Fibroid Embolization Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Nippon Kayaku
2.14.1 Nippon Kayaku Details
2.14.2 Nippon Kayaku Major Business
2.14.3 Nippon Kayaku Uterine Fibroid Embolization Device Product and Services
2.14.4 Nippon Kayaku Uterine Fibroid Embolization Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Pfizer
2.15.1 Pfizer Details
2.15.2 Pfizer Major Business
2.15.3 Pfizer Uterine Fibroid Embolization Device Product and Services
2.15.4 Pfizer Uterine Fibroid Embolization Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Uterine Fibroid Embolization Device Breakdown Data by Manufacturer
3.1 Global Uterine Fibroid Embolization Device Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Uterine Fibroid Embolization Device Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Uterine Fibroid Embolization Device
3.4 Market Concentration Rate
3.4.1 Top 3 Uterine Fibroid Embolization Device Manufacturer Market Share in 2021
3.4.2 Top 6 Uterine Fibroid Embolization Device Manufacturer Market Share in 2021
3.5 Global Uterine Fibroid Embolization Device Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Uterine Fibroid Embolization Device Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Uterine Fibroid Embolization Device Market Size by Region
4.1.1 Global Uterine Fibroid Embolization Device Sales in Volume by Region (2017-2028)
4.1.2 Global Uterine Fibroid Embolization Device Revenue by Region (2017-2028)
4.2 North America Uterine Fibroid Embolization Device Revenue (2017-2028)
4.3 Europe Uterine Fibroid Embolization Device Revenue (2017-2028)
4.4 Asia-Pacific Uterine Fibroid Embolization Device Revenue (2017-2028)
4.5 South America Uterine Fibroid Embolization Device Revenue (2017-2028)
4.6 Middle East and Africa Uterine Fibroid Embolization Device Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Uterine Fibroid Embolization Device Sales in Volume by Type (2017-2028)
5.2 Global Uterine Fibroid Embolization Device Revenue by Type (2017-2028)
5.3 Global Uterine Fibroid Embolization Device Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Uterine Fibroid Embolization Device Sales in Volume by Application (2017-2028)
6.2 Global Uterine Fibroid Embolization Device Revenue by Application (2017-2028)
6.3 Global Uterine Fibroid Embolization Device Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Uterine Fibroid Embolization Device Sales by Type (2017-2028)
7.2 North America Uterine Fibroid Embolization Device Sales by Application (2017-2028)
7.3 North America Uterine Fibroid Embolization Device Market Size by Country
7.3.1 North America Uterine Fibroid Embolization Device Sales in Volume by Country (2017-2028)
7.3.2 North America Uterine Fibroid Embolization Device Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Uterine Fibroid Embolization Device Sales by Type (2017-2028)
8.2 Europe Uterine Fibroid Embolization Device Sales by Application (2017-2028)
8.3 Europe Uterine Fibroid Embolization Device Market Size by Country
8.3.1 Europe Uterine Fibroid Embolization Device Sales in Volume by Country (2017-2028)
8.3.2 Europe Uterine Fibroid Embolization Device Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Uterine Fibroid Embolization Device Sales by Type (2017-2028)
9.2 Asia-Pacific Uterine Fibroid Embolization Device Sales by Application (2017-2028)
9.3 Asia-Pacific Uterine Fibroid Embolization Device Market Size by Region
9.3.1 Asia-Pacific Uterine Fibroid Embolization Device Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Uterine Fibroid Embolization Device Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Uterine Fibroid Embolization Device Sales by Type (2017-2028)
10.2 South America Uterine Fibroid Embolization Device Sales by Application (2017-2028)
10.3 South America Uterine Fibroid Embolization Device Market Size by Country
10.3.1 South America Uterine Fibroid Embolization Device Sales in Volume by Country (2017-2028)
10.3.2 South America Uterine Fibroid Embolization Device Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Uterine Fibroid Embolization Device Sales by Type (2017-2028)
11.2 Middle East & Africa Uterine Fibroid Embolization Device Sales by Application (2017-2028)
11.3 Middle East & Africa Uterine Fibroid Embolization Device Market Size by Country
11.3.1 Middle East & Africa Uterine Fibroid Embolization Device Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Uterine Fibroid Embolization Device Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Uterine Fibroid Embolization Device and Key Manufacturers
12.2 Manufacturing Costs Percentage of Uterine Fibroid Embolization Device
12.3 Uterine Fibroid Embolization Device Production Process
12.4 Uterine Fibroid Embolization Device Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Uterine Fibroid Embolization Device Typical Distributors
13.3 Uterine Fibroid Embolization Device Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Uterine Fibroid Embolization Device Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Uterine Fibroid Embolization Device Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Boston Scientific Corporation Basic Information, Manufacturing Base and Competitors
Table 4. Boston Scientific Corporation Major Business
Table 5. Boston Scientific Corporation Uterine Fibroid Embolization Device Product and Services
Table 6. Boston Scientific Corporation Uterine Fibroid Embolization Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Merit Medical Systems Basic Information, Manufacturing Base and Competitors
Table 8. Merit Medical Systems Major Business
Table 9. Merit Medical Systems Uterine Fibroid Embolization Device Product and Services
Table 10. Merit Medical Systems Uterine Fibroid Embolization Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. BioSpace Basic Information, Manufacturing Base and Competitors
Table 12. BioSpace Major Business
Table 13. BioSpace Uterine Fibroid Embolization Device Product and Services
Table 14. BioSpace Uterine Fibroid Embolization Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Hologic, Inc. Basic Information, Manufacturing Base and Competitors
Table 16. Hologic, Inc. Major Business
Table 17. Hologic, Inc. Uterine Fibroid Embolization Device Product and Services
Table 18. Hologic, Inc. Uterine Fibroid Embolization Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Cook Medical Basic Information, Manufacturing Base and Competitors
Table 20. Cook Medical Major Business
Table 21. Cook Medical Uterine Fibroid Embolization Device Product and Services
Table 22. Cook Medical Uterine Fibroid Embolization Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Ferring B.V. Basic Information, Manufacturing Base and Competitors
Table 24. Ferring B.V. Major Business
Table 25. Ferring B.V. Uterine Fibroid Embolization Device Product and Services
Table 26. Ferring B.V. Uterine Fibroid Embolization Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Smith+Nephew Basic Information, Manufacturing Base and Competitors
Table 28. Smith+Nephew Major Business
Table 29. Smith+Nephew Uterine Fibroid Embolization Device Product and Services
Table 30. Smith+Nephew Uterine Fibroid Embolization Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. CooperSurgical, Inc. Basic Information, Manufacturing Base and Competitors
Table 32. CooperSurgical, Inc. Major Business
Table 33. CooperSurgical, Inc. Uterine Fibroid Embolization Device Product and Services
Table 34. CooperSurgical, Inc. Uterine Fibroid Embolization Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Aetna Better Health of Pennsylvania Basic Information, Manufacturing Base and Competitors
Table 36. Aetna Better Health of Pennsylvania Major Business
Table 37. Aetna Better Health of Pennsylvania Uterine Fibroid Embolization Device Product and Services
Table 38. Aetna Better Health of Pennsylvania Uterine Fibroid Embolization Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Ethicon US, LLC Basic Information, Manufacturing Base and Competitors
Table 40. Ethicon US, LLC Major Business
Table 41. Ethicon US, LLC Uterine Fibroid Embolization Device Product and Services
Table 42. Ethicon US, LLC Uterine Fibroid Embolization Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Olympus America Basic Information, Manufacturing Base and Competitors
Table 44. Olympus America Major Business
Table 45. Olympus America Uterine Fibroid Embolization Device Product and Services
Table 46. Olympus America Uterine Fibroid Embolization Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Stryker Basic Information, Manufacturing Base and Competitors
Table 48. Stryker Major Business
Table 49. Stryker Uterine Fibroid Embolization Device Product and Services
Table 50. Stryker Uterine Fibroid Embolization Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 52. Astellas Pharma Major Business
Table 53. Astellas Pharma Uterine Fibroid Embolization Device Product and Services
Table 54. Astellas Pharma Uterine Fibroid Embolization Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Nippon Kayaku Basic Information, Manufacturing Base and Competitors
Table 56. Nippon Kayaku Major Business
Table 57. Nippon Kayaku Uterine Fibroid Embolization Device Product and Services
Table 58. Nippon Kayaku Uterine Fibroid Embolization Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Pfizer Basic Information, Manufacturing Base and Competitors
Table 60. Pfizer Major Business
Table 61. Pfizer Uterine Fibroid Embolization Device Product and Services
Table 62. Pfizer Uterine Fibroid Embolization Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Global Uterine Fibroid Embolization Device Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 64. Global Uterine Fibroid Embolization Device Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 65. Market Position of Manufacturers in Uterine Fibroid Embolization Device, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 66. Global Uterine Fibroid Embolization Device Production Capacity by Company, (K Units): 2020 VS 2021
Table 67. Head Office and Uterine Fibroid Embolization Device Production Site of Key Manufacturer
Table 68. Uterine Fibroid Embolization Device New Entrant and Capacity Expansion Plans
Table 69. Uterine Fibroid Embolization Device Mergers & Acquisitions in the Past Five Years
Table 70. Global Uterine Fibroid Embolization Device Sales by Region (2017-2022) & (K Units)
Table 71. Global Uterine Fibroid Embolization Device Sales by Region (2023-2028) & (K Units)
Table 72. Global Uterine Fibroid Embolization Device Revenue by Region (2017-2022) & (USD Million)
Table 73. Global Uterine Fibroid Embolization Device Revenue by Region (2023-2028) & (USD Million)
Table 74. Global Uterine Fibroid Embolization Device Sales by Type (2017-2022) & (K Units)
Table 75. Global Uterine Fibroid Embolization Device Sales by Type (2023-2028) & (K Units)
Table 76. Global Uterine Fibroid Embolization Device Revenue by Type (2017-2022) & (USD Million)
Table 77. Global Uterine Fibroid Embolization Device Revenue by Type (2023-2028) & (USD Million)
Table 78. Global Uterine Fibroid Embolization Device Price by Type (2017-2022) & (US$/Unit)
Table 79. Global Uterine Fibroid Embolization Device Price by Type (2023-2028) & (US$/Unit)
Table 80. Global Uterine Fibroid Embolization Device Sales by Application (2017-2022) & (K Units)
Table 81. Global Uterine Fibroid Embolization Device Sales by Application (2023-2028) & (K Units)
Table 82. Global Uterine Fibroid Embolization Device Revenue by Application (2017-2022) & (USD Million)
Table 83. Global Uterine Fibroid Embolization Device Revenue by Application (2023-2028) & (USD Million)
Table 84. Global Uterine Fibroid Embolization Device Price by Application (2017-2022) & (US$/Unit)
Table 85. Global Uterine Fibroid Embolization Device Price by Application (2023-2028) & (US$/Unit)
Table 86. North America Uterine Fibroid Embolization Device Sales by Country (2017-2022) & (K Units)
Table 87. North America Uterine Fibroid Embolization Device Sales by Country (2023-2028) & (K Units)
Table 88. North America Uterine Fibroid Embolization Device Revenue by Country (2017-2022) & (USD Million)
Table 89. North America Uterine Fibroid Embolization Device Revenue by Country (2023-2028) & (USD Million)
Table 90. North America Uterine Fibroid Embolization Device Sales by Type (2017-2022) & (K Units)
Table 91. North America Uterine Fibroid Embolization Device Sales by Type (2023-2028) & (K Units)
Table 92. North America Uterine Fibroid Embolization Device Sales by Application (2017-2022) & (K Units)
Table 93. North America Uterine Fibroid Embolization Device Sales by Application (2023-2028) & (K Units)
Table 94. Europe Uterine Fibroid Embolization Device Sales by Country (2017-2022) & (K Units)
Table 95. Europe Uterine Fibroid Embolization Device Sales by Country (2023-2028) & (K Units)
Table 96. Europe Uterine Fibroid Embolization Device Revenue by Country (2017-2022) & (USD Million)
Table 97. Europe Uterine Fibroid Embolization Device Revenue by Country (2023-2028) & (USD Million)
Table 98. Europe Uterine Fibroid Embolization Device Sales by Type (2017-2022) & (K Units)
Table 99. Europe Uterine Fibroid Embolization Device Sales by Type (2023-2028) & (K Units)
Table 100. Europe Uterine Fibroid Embolization Device Sales by Application (2017-2022) & (K Units)
Table 101. Europe Uterine Fibroid Embolization Device Sales by Application (2023-2028) & (K Units)
Table 102. Asia-Pacific Uterine Fibroid Embolization Device Sales by Region (2017-2022) & (K Units)
Table 103. Asia-Pacific Uterine Fibroid Embolization Device Sales by Region (2023-2028) & (K Units)
Table 104. Asia-Pacific Uterine Fibroid Embolization Device Revenue by Region (2017-2022) & (USD Million)
Table 105. Asia-Pacific Uterine Fibroid Embolization Device Revenue by Region (2023-2028) & (USD Million)
Table 106. Asia-Pacific Uterine Fibroid Embolization Device Sales by Type (2017-2022) & (K Units)
Table 107. Asia-Pacific Uterine Fibroid Embolization Device Sales by Type (2023-2028) & (K Units)
Table 108. Asia-Pacific Uterine Fibroid Embolization Device Sales by Application (2017-2022) & (K Units)
Table 109. Asia-Pacific Uterine Fibroid Embolization Device Sales by Application (2023-2028) & (K Units)
Table 110. South America Uterine Fibroid Embolization Device Sales by Country (2017-2022) & (K Units)
Table 111. South America Uterine Fibroid Embolization Device Sales by Country (2023-2028) & (K Units)
Table 112. South America Uterine Fibroid Embolization Device Revenue by Country (2017-2022) & (USD Million)
Table 113. South America Uterine Fibroid Embolization Device Revenue by Country (2023-2028) & (USD Million)
Table 114. South America Uterine Fibroid Embolization Device Sales by Type (2017-2022) & (K Units)
Table 115. South America Uterine Fibroid Embolization Device Sales by Type (2023-2028) & (K Units)
Table 116. South America Uterine Fibroid Embolization Device Sales by Application (2017-2022) & (K Units)
Table 117. South America Uterine Fibroid Embolization Device Sales by Application (2023-2028) & (K Units)
Table 118. Middle East & Africa Uterine Fibroid Embolization Device Sales by Region (2017-2022) & (K Units)
Table 119. Middle East & Africa Uterine Fibroid Embolization Device Sales by Region (2023-2028) & (K Units)
Table 120. Middle East & Africa Uterine Fibroid Embolization Device Revenue by Region (2017-2022) & (USD Million)
Table 121. Middle East & Africa Uterine Fibroid Embolization Device Revenue by Region (2023-2028) & (USD Million)
Table 122. Middle East & Africa Uterine Fibroid Embolization Device Sales by Type (2017-2022) & (K Units)
Table 123. Middle East & Africa Uterine Fibroid Embolization Device Sales by Type (2023-2028) & (K Units)
Table 124. Middle East & Africa Uterine Fibroid Embolization Device Sales by Application (2017-2022) & (K Units)
Table 125. Middle East & Africa Uterine Fibroid Embolization Device Sales by Application (2023-2028) & (K Units)
Table 126. Uterine Fibroid Embolization Device Raw Material
Table 127. Key Manufacturers of Uterine Fibroid Embolization Device Raw Materials
Table 128. Direct Channel Pros & Cons
Table 129. Indirect Channel Pros & Cons
Table 130. Uterine Fibroid Embolization Device Typical Distributors
Table 131. Uterine Fibroid Embolization Device Typical Customers
List of Figures
Figure 1. Uterine Fibroid Embolization Device Picture
Figure 2. Global Uterine Fibroid Embolization Device Revenue Market Share by Type in 2021
Figure 3. Gelatin Sponge
Figure 4. Polyvinyl Alcohol ( PVA ) Particles
Figure 5. Trisacryl Gelatin Microspheres ( TAGM )
Figure 6. Polymethyl Methacrylate ( PMMA ) Microspheres
Figure 7. Global Uterine Fibroid Embolization Device Revenue Market Share by Application in 2021
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Global Uterine Fibroid Embolization Device Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 11. Global Uterine Fibroid Embolization Device Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Uterine Fibroid Embolization Device Sales (2017-2028) & (K Units)
Figure 13. Global Uterine Fibroid Embolization Device Price (2017-2028) & (US$/Unit)
Figure 14. Global Uterine Fibroid Embolization Device Production Capacity (2017-2028) & (K Units)
Figure 15. Global Uterine Fibroid Embolization Device Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Uterine Fibroid Embolization Device Market Drivers
Figure 17. Uterine Fibroid Embolization Device Market Restraints
Figure 18. Uterine Fibroid Embolization Device Market Trends
Figure 19. Global Uterine Fibroid Embolization Device Sales Market Share by Manufacturer in 2021
Figure 20. Global Uterine Fibroid Embolization Device Revenue Market Share by Manufacturer in 2021
Figure 21. Uterine Fibroid Embolization Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Uterine Fibroid Embolization Device Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Uterine Fibroid Embolization Device Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Uterine Fibroid Embolization Device Sales Market Share by Region (2017-2028)
Figure 25. Global Uterine Fibroid Embolization Device Revenue Market Share by Region (2017-2028)
Figure 26. North America Uterine Fibroid Embolization Device Revenue (2017-2028) & (USD Million)
Figure 27. Europe Uterine Fibroid Embolization Device Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Uterine Fibroid Embolization Device Revenue (2017-2028) & (USD Million)
Figure 29. South America Uterine Fibroid Embolization Device Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Uterine Fibroid Embolization Device Revenue (2017-2028) & (USD Million)
Figure 31. Global Uterine Fibroid Embolization Device Sales Market Share by Type (2017-2028)
Figure 32. Global Uterine Fibroid Embolization Device Revenue Market Share by Type (2017-2028)
Figure 33. Global Uterine Fibroid Embolization Device Price by Type (2017-2028) & (US$/Unit)
Figure 34. Global Uterine Fibroid Embolization Device Sales Market Share by Application (2017-2028)
Figure 35. Global Uterine Fibroid Embolization Device Revenue Market Share by Application (2017-2028)
Figure 36. Global Uterine Fibroid Embolization Device Price by Application (2017-2028) & (US$/Unit)
Figure 37. North America Uterine Fibroid Embolization Device Sales Market Share by Type (2017-2028)
Figure 38. North America Uterine Fibroid Embolization Device Sales Market Share by Application (2017-2028)
Figure 39. North America Uterine Fibroid Embolization Device Sales Market Share by Country (2017-2028)
Figure 40. North America Uterine Fibroid Embolization Device Revenue Market Share by Country (2017-2028)
Figure 41. United States Uterine Fibroid Embolization Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Uterine Fibroid Embolization Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Uterine Fibroid Embolization Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Uterine Fibroid Embolization Device Sales Market Share by Type (2017-2028)
Figure 45. Europe Uterine Fibroid Embolization Device Sales Market Share by Application (2017-2028)
Figure 46. Europe Uterine Fibroid Embolization Device Sales Market Share by Country (2017-2028)
Figure 47. Europe Uterine Fibroid Embolization Device Revenue Market Share by Country (2017-2028)
Figure 48. Germany Uterine Fibroid Embolization Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Uterine Fibroid Embolization Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Uterine Fibroid Embolization Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Uterine Fibroid Embolization Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Uterine Fibroid Embolization Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Uterine Fibroid Embolization Device Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Uterine Fibroid Embolization Device Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Uterine Fibroid Embolization Device Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Uterine Fibroid Embolization Device Revenue Market Share by Region (2017-2028)
Figure 57. China Uterine Fibroid Embolization Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Uterine Fibroid Embolization Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Uterine Fibroid Embolization Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Uterine Fibroid Embolization Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Uterine Fibroid Embolization Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Uterine Fibroid Embolization Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Uterine Fibroid Embolization Device Sales Market Share by Type (2017-2028)
Figure 64. South America Uterine Fibroid Embolization Device Sales Market Share by Application (2017-2028)
Figure 65. South America Uterine Fibroid Embolization Device Sales Market Share by Country (2017-2028)
Figure 66. South America Uterine Fibroid Embolization Device Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Uterine Fibroid Embolization Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Uterine Fibroid Embolization Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Uterine Fibroid Embolization Device Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Uterine Fibroid Embolization Device Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Uterine Fibroid Embolization Device Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Uterine Fibroid Embolization Device Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Uterine Fibroid Embolization Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Uterine Fibroid Embolization Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Uterine Fibroid Embolization Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Uterine Fibroid Embolization Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Uterine Fibroid Embolization Device in 2021
Figure 78. Manufacturing Process Analysis of Uterine Fibroid Embolization Device
Figure 79. Uterine Fibroid Embolization Device Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の嚢内血流遮断装置市場2022年：市場規模予測（～2028年）
  • 子宮マニピュレーターの世界市場 2022年-2026年
  • 子宮ポリープ鉗子のグローバル市場展望 2023年-2029年：直線、曲線
  • 使い捨て子宮マニピュレーターのグローバル市場展望 2023年-2029年：ストレートシャフト、カーブシャフト
  • 子宮用シリンジのグローバル市場展望 2023年-2029年：使い捨て式、再利用可能式
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO18708 )"世界の子宮筋腫塞栓装置市場2022年：市場規模予測（～2028年）" (英文：Global Uterine Fibroid Embolization Device Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。